DeepPriorCBCT for Low Dose Lung CBCT Reconstruction
NCT07035977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138
Last updated 2025-12-18
Summary
The goal of this clinical trial is to learn if the DeepPriorCBCT model ensure high-quality CBCT image while reducing CBCT radiation dose. The main questions it aims to answer are:
* Can DeepPriorCBCT reduce CBCT radiation doses?
* Is the image quality of DeepPriorCBCT reconstruction consistent with that of existing clinical reconstruction method? Researchers will compare CBCT images quality reconstruction with DeepPriorCBCT model to CBCT image quality reconstruction with existing clinical protocols to see if DeepPriorCBCT model can improve the CBCT image quality while reducing radiation dose.
Participants will:
* Receive a single low dose (1/6 of existing clinical protocols) CBCT scan
* Receive a single conventional dose CBCT scan
Conditions
- Lung Nodules
Interventions
- RADIATION
-
Participants will receive a 1/6 views undersampling lung CBCT scan.
Participants will receive a 1/6 views undersampling lung CBCT scan. And the CBCT images will be reconstructed by DeepPriorCBCT model for further analysis.
Sponsors & Collaborators
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-15
- Primary Completion
- 2025-07-15
- Completion
- 2025-07-20
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors
NCT06203574 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence and Bone Tomoscintigraphies Achieved With CZT Camera
NCT06281015 ·Status: COMPLETED
-
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110 ·Status: RECRUITING ·Phase: NA
-
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299 ·Status: NOT_YET_RECRUITING
-
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814 ·Status: RECRUITING
-
Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesions
NCT07149597 ·Status: NOT_YET_RECRUITING
-
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
NCT06852807 ·Status: RECRUITING
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Integrin αvβ6-targeted PET in Malignant Tumors
NCT05835570 ·Status: RECRUITING
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans
NCT05110430 ·Status: COMPLETED
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
Imaging Multiparametric/Multimodality for Lungcancer
NCT02977663 ·Status: UNKNOWN ·Phase: NA
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of 18F -FAPI-RGD in Renal Tumor
NCT05976607 ·Status: COMPLETED
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
NCT04942275 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Clinical Study of Trap (FAPI) 3 PET Imaging in Noninvasive Diagnosis of Malignant Tumors
NCT07128277 ·Status: NOT_YET_RECRUITING
-
MRI Perfusion on T1 and T2 Brain Lesion(s)
NCT02250755 ·Status: COMPLETED ·Phase: NA
-
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung
NCT01741597 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
NCT06148155 ·Status: RECRUITING ·Phase: NA
-
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028 ·Status: RECRUITING ·Phase: NA
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2